Skip to content

Clinical trials

Phase 1 Breast Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1 Country / region: South Korea Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20093
20101
20111
20122
20132
20141
20162
20173
20186
20195
20205
20211
20222
20231
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting8
Terminated7
Recruiting5
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
GlaxoSmithKline5
Novartis Pharmaceuticals4
AstraZeneca2
Genentech, Inc.2
Hoffmann-La Roche2
AbbVie1
Alterome Therapeutics, Inc.1
Asan Medical Center1
Astellas Pharma Global Development, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms44
Neoplasms14
Carcinoma, Non-Small-Cell Lung10
Stomach Neoplasms10
Colorectal Neoplasms9
Ovarian Neoplasms9
Endometrial Neoplasms6
Pancreatic Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Head and Neck Neoplasms4

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.